Commercialisation Entities

Exploit Technologies Pte Ltd (ETPL) ETPL, the technology transfer arm of A*STAR, manages the intellectual property portfolio of A*STAR’s research institutes and centres. It promotes the institutes’ research capabilities and facilitates the efficient transfer of A*STAR’s technologies to industry, ensuring that new intellectual properties generated by our researchers are exploited to produce tangible products and services. Through adoption of these technologies, companies can be more globally competitive and thereby grow to create more high value-added jobs. Visit ETPL's website http://www.exploit-tech.com

Experimental Therapeutics Centre (ETC) ETC was set up to play an increasingly important role in translating scientific discoveries into practical applications. From engaging in early stage drug discovery and development, to developing innovative research tools for clinical analysis, as well as setting up public-private partnerships to facilitate the advancement of drug candidates, ETC augments Singapore’s capabilities and resources in this spectrum of the drug discovery process. It is currently headed by CEO Dr Alex Matter. Visit ETC's website http://www.etc.a-star.edu.sg

BMRC Industry Development Group (IDG) The Industry Development Group (IDG) supports the advancement of early-stage discoveries at the A*STAR research institutes under the Biomedical Research Council. IDG facilitates the BMRC researchers on advancing their early-stage discoveries through early intellectual property identification and development of business ideas and translate their discoveries into commercial products through collaborations with industry partners and academic institutions, and the formation of new ventures. Visit IDG's website http://www.idg.a-star.edu.sg

Back to Top